Cargando…

A systems view of type 2 diabetes-associated metabolic perturbations in saliva, blood and urine at different timescales of glycaemic control

AIMS/HYPOTHESIS: Metabolomics has opened new avenues for studying metabolic alterations in type 2 diabetes. While many urine and blood metabolites have been associated individually with diabetes, a complete systems view analysis of metabolic dysregulations across multiple biofluids and over varying...

Descripción completa

Detalles Bibliográficos
Autores principales: Yousri, Noha A., Mook-Kanamori, Dennis O., Selim, Mohammed M. El-Din, Takiddin, Ahmed H., Al-Homsi, Hala, Al-Mahmoud, Khoulood A. S., Karoly, Edward D., Krumsiek, Jan, Do, Kieu Thinh, Neumaier, Ulrich, Mook-Kanamori, Marjonneke J., Rowe, Jillian, Chidiac, Omar M., McKeon, Cindy, Al Muftah, Wadha A., Kader, Sara Abdul, Kastenmüller, Gabi, Suhre, Karsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4499109/
https://www.ncbi.nlm.nih.gov/pubmed/26049400
http://dx.doi.org/10.1007/s00125-015-3636-2
_version_ 1782380726343172096
author Yousri, Noha A.
Mook-Kanamori, Dennis O.
Selim, Mohammed M. El-Din
Takiddin, Ahmed H.
Al-Homsi, Hala
Al-Mahmoud, Khoulood A. S.
Karoly, Edward D.
Krumsiek, Jan
Do, Kieu Thinh
Neumaier, Ulrich
Mook-Kanamori, Marjonneke J.
Rowe, Jillian
Chidiac, Omar M.
McKeon, Cindy
Al Muftah, Wadha A.
Kader, Sara Abdul
Kastenmüller, Gabi
Suhre, Karsten
author_facet Yousri, Noha A.
Mook-Kanamori, Dennis O.
Selim, Mohammed M. El-Din
Takiddin, Ahmed H.
Al-Homsi, Hala
Al-Mahmoud, Khoulood A. S.
Karoly, Edward D.
Krumsiek, Jan
Do, Kieu Thinh
Neumaier, Ulrich
Mook-Kanamori, Marjonneke J.
Rowe, Jillian
Chidiac, Omar M.
McKeon, Cindy
Al Muftah, Wadha A.
Kader, Sara Abdul
Kastenmüller, Gabi
Suhre, Karsten
author_sort Yousri, Noha A.
collection PubMed
description AIMS/HYPOTHESIS: Metabolomics has opened new avenues for studying metabolic alterations in type 2 diabetes. While many urine and blood metabolites have been associated individually with diabetes, a complete systems view analysis of metabolic dysregulations across multiple biofluids and over varying timescales of glycaemic control is still lacking. METHODS: Here we report a broad metabolomics study in a clinical setting, covering 2,178 metabolite measures in saliva, blood plasma and urine from 188 individuals with diabetes and 181 controls of Arab and Asian descent. Using multivariate linear regression we identified metabolites associated with diabetes and markers of acute, short-term and long-term glycaemic control. RESULTS: Ninety-four metabolite associations with diabetes were identified at a Bonferroni level of significance (p < 2.3 × 10(−5)), 16 of which have never been reported. Sixty-five of these diabetes-associated metabolites were associated with at least one marker of glycaemic control in the diabetes group. Using Gaussian graphical modelling, we constructed a metabolic network that links diabetes-associated metabolites from three biofluids across three different timescales of glycaemic control. CONCLUSIONS/INTERPRETATION: Our study reveals a complex network of biochemical dysregulation involving metabolites from different pathways of diabetes pathology, and provides a reference framework for future diabetes studies with metabolic endpoints. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00125-015-3636-2) contains peer-reviewed but unedited supplementary material, which is available to authorised users.
format Online
Article
Text
id pubmed-4499109
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-44991092015-07-16 A systems view of type 2 diabetes-associated metabolic perturbations in saliva, blood and urine at different timescales of glycaemic control Yousri, Noha A. Mook-Kanamori, Dennis O. Selim, Mohammed M. El-Din Takiddin, Ahmed H. Al-Homsi, Hala Al-Mahmoud, Khoulood A. S. Karoly, Edward D. Krumsiek, Jan Do, Kieu Thinh Neumaier, Ulrich Mook-Kanamori, Marjonneke J. Rowe, Jillian Chidiac, Omar M. McKeon, Cindy Al Muftah, Wadha A. Kader, Sara Abdul Kastenmüller, Gabi Suhre, Karsten Diabetologia Article AIMS/HYPOTHESIS: Metabolomics has opened new avenues for studying metabolic alterations in type 2 diabetes. While many urine and blood metabolites have been associated individually with diabetes, a complete systems view analysis of metabolic dysregulations across multiple biofluids and over varying timescales of glycaemic control is still lacking. METHODS: Here we report a broad metabolomics study in a clinical setting, covering 2,178 metabolite measures in saliva, blood plasma and urine from 188 individuals with diabetes and 181 controls of Arab and Asian descent. Using multivariate linear regression we identified metabolites associated with diabetes and markers of acute, short-term and long-term glycaemic control. RESULTS: Ninety-four metabolite associations with diabetes were identified at a Bonferroni level of significance (p < 2.3 × 10(−5)), 16 of which have never been reported. Sixty-five of these diabetes-associated metabolites were associated with at least one marker of glycaemic control in the diabetes group. Using Gaussian graphical modelling, we constructed a metabolic network that links diabetes-associated metabolites from three biofluids across three different timescales of glycaemic control. CONCLUSIONS/INTERPRETATION: Our study reveals a complex network of biochemical dysregulation involving metabolites from different pathways of diabetes pathology, and provides a reference framework for future diabetes studies with metabolic endpoints. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00125-015-3636-2) contains peer-reviewed but unedited supplementary material, which is available to authorised users. Springer Berlin Heidelberg 2015-06-07 2015 /pmc/articles/PMC4499109/ /pubmed/26049400 http://dx.doi.org/10.1007/s00125-015-3636-2 Text en © The Author(s) 2015 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Article
Yousri, Noha A.
Mook-Kanamori, Dennis O.
Selim, Mohammed M. El-Din
Takiddin, Ahmed H.
Al-Homsi, Hala
Al-Mahmoud, Khoulood A. S.
Karoly, Edward D.
Krumsiek, Jan
Do, Kieu Thinh
Neumaier, Ulrich
Mook-Kanamori, Marjonneke J.
Rowe, Jillian
Chidiac, Omar M.
McKeon, Cindy
Al Muftah, Wadha A.
Kader, Sara Abdul
Kastenmüller, Gabi
Suhre, Karsten
A systems view of type 2 diabetes-associated metabolic perturbations in saliva, blood and urine at different timescales of glycaemic control
title A systems view of type 2 diabetes-associated metabolic perturbations in saliva, blood and urine at different timescales of glycaemic control
title_full A systems view of type 2 diabetes-associated metabolic perturbations in saliva, blood and urine at different timescales of glycaemic control
title_fullStr A systems view of type 2 diabetes-associated metabolic perturbations in saliva, blood and urine at different timescales of glycaemic control
title_full_unstemmed A systems view of type 2 diabetes-associated metabolic perturbations in saliva, blood and urine at different timescales of glycaemic control
title_short A systems view of type 2 diabetes-associated metabolic perturbations in saliva, blood and urine at different timescales of glycaemic control
title_sort systems view of type 2 diabetes-associated metabolic perturbations in saliva, blood and urine at different timescales of glycaemic control
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4499109/
https://www.ncbi.nlm.nih.gov/pubmed/26049400
http://dx.doi.org/10.1007/s00125-015-3636-2
work_keys_str_mv AT yousrinohaa asystemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol
AT mookkanamoridenniso asystemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol
AT selimmohammedmeldin asystemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol
AT takiddinahmedh asystemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol
AT alhomsihala asystemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol
AT almahmoudkhouloodas asystemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol
AT karolyedwardd asystemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol
AT krumsiekjan asystemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol
AT dokieuthinh asystemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol
AT neumaierulrich asystemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol
AT mookkanamorimarjonnekej asystemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol
AT rowejillian asystemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol
AT chidiacomarm asystemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol
AT mckeoncindy asystemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol
AT almuftahwadhaa asystemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol
AT kadersaraabdul asystemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol
AT kastenmullergabi asystemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol
AT suhrekarsten asystemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol
AT yousrinohaa systemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol
AT mookkanamoridenniso systemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol
AT selimmohammedmeldin systemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol
AT takiddinahmedh systemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol
AT alhomsihala systemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol
AT almahmoudkhouloodas systemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol
AT karolyedwardd systemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol
AT krumsiekjan systemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol
AT dokieuthinh systemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol
AT neumaierulrich systemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol
AT mookkanamorimarjonnekej systemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol
AT rowejillian systemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol
AT chidiacomarm systemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol
AT mckeoncindy systemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol
AT almuftahwadhaa systemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol
AT kadersaraabdul systemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol
AT kastenmullergabi systemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol
AT suhrekarsten systemsviewoftype2diabetesassociatedmetabolicperturbationsinsalivabloodandurineatdifferenttimescalesofglycaemiccontrol